Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Antonio Toscano

Showing results (141-150 of 223) with videos related to

Pageof 23
Sort By:
The Lancet. Neurology|November 20, 2021
Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trialBenedikt Schoser, Mark Roberts, Barry J Byrne, et al.
Neuromuscular Disorders : NMD|June 9, 2005
Comparison of different techniques for detecting 17p12 duplication in CMT1AAlessandra Patitucci, Maria Muglia, Angela Magariello, et al.
European Journal of Neurology|June 13, 2025
What Are the Normal Serum Creatine Kinase Values for Skeletal Muscle? A Worldwide Systematic ReviewKatina Aleksovska, Theodoros Kyriakides, Corrado Angelini, et al.
Journal of the Neurological Sciences|September 5, 2023
Factors associated with hemorrhagic transformation after endovascular treatment despite early recanalizationAntonio Ciacciarelli, Agostino Tessitore, Giulia Fiume, et al.
Frontiers in Neurology|March 16, 2019
Lipomatosis Incidence and Characteristics in an Italian Cohort of Mitochondrial PatientsOlimpia Musumeci, Emanuele Barca, Costanza Lamperti, et al.
Orphanet Journal of Rare Diseases|October 27, 2023
Safety outcomes and patients' preferences for home-based intravenous enzyme replacement therapy (ERT) in pompe disease and mucopolysaccharidosis type I (MPS I) disorder: COVID-19 and beyondAntonio Toscano, Olimpia Musumeci, Michele Sacchini, et al.
Journal of the Neurological Sciences|January 16, 2022
Repeated reperfusion treatment in recurrent ischemic stroke: A retrospective single-center case seriesCristina Dell'Aera, Fabrizio Giammello, Antonio Armando Caragliano, et al.
Journal of Neuromuscular Diseases|May 10, 2024
E-Health & Innovation to Overcome Barriers in Neuromuscular Diseases. Report from the 3rd eNMD Congress: Pisa, Italy, 29-30 October 2021: Remote Monitoring: New Solutions for New Avenues in Neuromuscular DisordersErika Schirinzi, Mario Alessandro Bochicchio, Hanns Lochmüller, et al.
Marine Environmental Research|June 4, 2025
Holocene mollusks and paleogeographical evolution of the doñana national park, Europe's largest biological reserve: A reviewGabriel Gómez, Francisco Ruiz, María Luz González-Regalado, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 26, 2024
Continuous stellate ganglion block for ventricular arrhythmias: case series, systematic review, and differences from thoracic epidural anaesthesiaVeronica Dusi, Filippo Angelini, Enrico Baldi, et al.
Pageof 23

Showing results (141-150 of 223) with videos related to

Sort By:
Pageof 23
The Lancet. Neurology|November 20, 2021
Safety and efficacy of cipaglucosidase alfa plus miglustat versus alglucosidase alfa plus placebo in late-onset Pompe disease (PROPEL): an international, randomised, double-blind, parallel-group, phase 3 trialBenedikt Schoser, Mark Roberts, Barry J Byrne, et al.
Neuromuscular Disorders : NMD|June 9, 2005
Comparison of different techniques for detecting 17p12 duplication in CMT1AAlessandra Patitucci, Maria Muglia, Angela Magariello, et al.
European Journal of Neurology|June 13, 2025
What Are the Normal Serum Creatine Kinase Values for Skeletal Muscle? A Worldwide Systematic ReviewKatina Aleksovska, Theodoros Kyriakides, Corrado Angelini, et al.
Journal of the Neurological Sciences|September 5, 2023
Factors associated with hemorrhagic transformation after endovascular treatment despite early recanalizationAntonio Ciacciarelli, Agostino Tessitore, Giulia Fiume, et al.
Frontiers in Neurology|March 16, 2019
Lipomatosis Incidence and Characteristics in an Italian Cohort of Mitochondrial PatientsOlimpia Musumeci, Emanuele Barca, Costanza Lamperti, et al.
Orphanet Journal of Rare Diseases|October 27, 2023
Safety outcomes and patients' preferences for home-based intravenous enzyme replacement therapy (ERT) in pompe disease and mucopolysaccharidosis type I (MPS I) disorder: COVID-19 and beyondAntonio Toscano, Olimpia Musumeci, Michele Sacchini, et al.
Journal of the Neurological Sciences|January 16, 2022
Repeated reperfusion treatment in recurrent ischemic stroke: A retrospective single-center case seriesCristina Dell'Aera, Fabrizio Giammello, Antonio Armando Caragliano, et al.
Journal of Neuromuscular Diseases|May 10, 2024
E-Health & Innovation to Overcome Barriers in Neuromuscular Diseases. Report from the 3rd eNMD Congress: Pisa, Italy, 29-30 October 2021: Remote Monitoring: New Solutions for New Avenues in Neuromuscular DisordersErika Schirinzi, Mario Alessandro Bochicchio, Hanns Lochmüller, et al.
Marine Environmental Research|June 4, 2025
Holocene mollusks and paleogeographical evolution of the doñana national park, Europe's largest biological reserve: A reviewGabriel Gómez, Francisco Ruiz, María Luz González-Regalado, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|March 26, 2024
Continuous stellate ganglion block for ventricular arrhythmias: case series, systematic review, and differences from thoracic epidural anaesthesiaVeronica Dusi, Filippo Angelini, Enrico Baldi, et al.
Pageof 23